top of page
Profile
Join date: Sep 27, 2020
Posts
Apr 4, 2024 ∙ 2 min
Zevtera FDA approval
FDA's approval of Basilea's 5th-generation cephalosporin antibiotic Zevtera (ceftobiprole) represents the successful culmination of the...
181
0
Feb 13, 2024 ∙ 3 min
Basilea full-year results - Strong execution
FY'23 has been a year of excellent financial and strategic execution. FY'23 revenues of CHF157.6m were once again dominated by strong...
122
0
Jan 19, 2024 ∙ 2 min
Basilea - Cresemba LatAm milestone
Given all of the strategic progress that Basilea has accomplished in recent months to replenish the anti-infectives pipeline, it would be...
63
0
Brian White
Writer
More actions
bottom of page